Paget's bone disease in a nonendemic region: Exploring novel therapeutic strategies.

Autor: Razavianzadeh, Nasrin¹ (AUTHOR), Shahramirad, Soheil^1,2 (AUTHOR), Hasani, Mohammad¹ (AUTHOR), Babaei, Hessamedin^1,2 (AUTHOR) hessamedin.b@gmail.com

Publikováno v: Clinical Case Reports. Sep2024, Vol. 12 Issue 9, p1-7. 7p.

Clinical and demographic aspects of Paget disease of bone: A multicentric study from Turkey.

Autor: Yavuz, Dilek Gogas¹ dilekgogas@marmara.edu.tr, Aytürk, Semra², Çetinkalp, Şevki³, Bayraktar, Fırat⁴, Kulaksızoğlu, Mustafa⁵, Hekimsoy, Zeliha⁶, Aydın, Hasan⁷, Uygur, Melin⁸, Deniz, Ferhat⁹, İpekçi, Süleyman¹⁰, Atmaca, Ayşegül¹¹, Saraç, Fulden¹², Özdemir, Nilüfer⁶, Cantürk, Zeynep¹³, Mert, Meral¹⁴, Sancak, Seda¹⁵, Ertörer, Eda¹⁶, Duran, Cevdet¹⁷, Akarsu, Ersin¹⁸, Deyneli, Oğuzhan¹⁹

Publikováno v: European Journal of Rheumatology. Jul2021, Vol. 8 Issue 3, p156-161. 6p.

Effect of a Three‐Day Course of Dexamethasone on Acute Phase Response Following Treatment With Zoledronate: A Randomized Controlled Trial.

Autor: Murdoch, Rachel, Mellar, Anna, Horne, Anne M., Billington, Emma, Chan, Pui Ling, Gamble, Gregory D., Reid, Ian R.

Publikováno v: Journal of Bone & Mineral Research; May2023, Vol. 38 Issue 5, p631-638, 8p

Safety and effectiveness of risedronate in Paget's disease of bone: postmarketing surveillance study in Japan.

Autor: Hashimoto J; National Hospital Organization Osaka Minami Medical Center, 2-1, Kido Higashimachi, Kawachinagano, Osaka, 586-8521, Japan., Arai Y; Medical Department, EA Pharma Co., Ltd., 2-1-1, Irifune, Chuo-ku, Tokyo, 104-0042, Japan. yuki_arai@eapharma.co.jp., Kurosu S; Data Science Group, Clinical Development Department, EA Pharma Co., Ltd., 2-1-1, Irifune, Chuo-ku, Tokyo, 104-0042, Japan., Ikezaki T; Clinical Planning and Development Department, Medical Headquarters, Eisai Co., Ltd., 4-6-10, Koishikawa, Bunkyo-ku, Tokyo, 112-8088, Japan.

Publikováno v: Journal of bone and mineral metabolism [J Bone Miner Metab] 2024 Jan; Vol. 42 (1), pp. 122-133. Date of Electronic Publication: 2024 Jan 10.

Quality of life and health care consumption in primary care patients with elevated serum calcium concentrations in - a prospective, case control, study.

Autor: Dalemo, Sofia^1,2 sofia.dalemo@vgregion.se, Eggertsen, Robert^1,3 robert.eggertsen@vgregion.se, Hjerpe, Per² per.hjerpe@vgregion.se, Jansson, Svante⁴ svante.jansson@vgregion.se, Boström, Kristina Bengtsson^1,2 kristina.a.bengtsson@vgregion.se

Publikováno v: BMC Family Practice. 2014, Vol. 15 Issue 1, p1-15. 15p. 1 Diagram, 3 Charts, 1 Graph.